-
公开(公告)号:EP3536345A1
公开(公告)日:2019-09-11
申请号:EP19169083.3
申请日:2015-05-06
发明人: RAY, Sangeeta , POMPER, Martin G. , MEADE, Thomas J. , MEASE, Ronnie C , CHEN, Ying , YANG, Xing , ROTZ, Matthew
IPC分类号: A61K51/04 , A61K49/00 , A61K49/10 , A61P35/00 , A61K49/12 , A61K51/06 , C07D257/02 , C07D403/14 , A61K103/00 , A61K103/20 , A61K103/30 , A61K103/32
摘要: Low-molecular weight gadolinium (Gd)-based MR contrast agents for PSMA-specific Ti-weighted MR imaging are disclosed. The (Gd)-based MR contrast agents exhibit high binding affinity for PSMA and exhibit specific T 1 contrast enhancement at PSMA+ cells. The PSMA-targeted Gd-based MR contrast agents can be used for PSMA-targeted imaging in vivo. 86 Y-labeled PSMA-binding ureas also are provided, wherein the PSMA-binding ureas also are suitable for use with other radiotherapeutics.
-
公开(公告)号:EP3964498A1
公开(公告)日:2022-03-09
申请号:EP21198593.2
申请日:2010-03-19
发明人: POMPER, Martin G , MEASE, Ronnie C , RAY, Sangeeta , CHEN, Ying
IPC分类号: C07D209/10 , C07D311/82 , A61K31/352 , A61K49/00 , A61P35/00
摘要: Prostate-specific membrane antigen (PSMA) targeting compounds are described. Uses of the compounds for imaging, therapy, cell sorting, and tumor mapping are also described.
-
公开(公告)号:EP3524277A1
公开(公告)日:2019-08-14
申请号:EP19163516.8
申请日:2012-11-30
摘要: The present invention provides a compound contains a PSMA binding Lys-Glu urea moiety linked to DOTA in complex with 111 In 3+ and its use in imaging PSMA cells.
-
-